Investor Relations

Transcat (Nasdaq:TRNS) has been a leader in the test and measurement industry for over 40 years. We strive to differentiate ourselves and build barriers to competitive entry by offering the best products, delivering high quality calibration and repair services, and integrating those products and services. We work diligently to create lasting value for our shareholders.

Strategic Overview

Our strategy is to continue to grow our business through a blend of organic revenue growth and acquisitions. We leverage the complementary nature of our operating segments in ways that add value for all customers who select Transcat as their source for test and measurement equipment and/or calibration and laboratory instrument services.

We believe our combined Service and Distribution segment offerings, experience, technical expertise and quality-oriented, integrity-based approach create a unique and compelling value proposition for our customers. We strive to differentiate ourselves within the markets we serve and build barriers to competitive entry by offering a broad range of the best products and services, and integrating those products and services to benefit our customers’ operations.

Upcoming & Past Events

Investor Information

Presentations

View our most recent Investor Presentations.

Presentations Company Profile

Annual Reports

View our Annual Reports from 2005-present.

Annual Reports

Earnings Releases

View our quarterly Earnings Releases from 2006-present.

Earnings Releases

SEC Filings

View our SEC filings on the SEC’s Electronic EDGAR System.

SEC Filings

Recent Company News

Southeastern Biomedical

Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical

Transcat announced that it has acquired privately-held Southeastern Biomedical Associates Incorporated (“Southeastern”) effective August 31, 2026.

Continue Reading
Investor Conference

Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September

Transcat management management will attend the 2026 Jefferies Global Industrials Conference, Lake Street Capital Markets 10th Annual Best Ideas Growth (“BIG10”) Conference, and D.A. Davidson 25th Annual Diversified Industrials & Services Conference in September 2026.

Continue Reading

Transcat Reports Strong Fiscal First Quarter 2027 Financial Results

Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leader in test measurement, control and calibration, has reported its financial and operational results for its fiscal first quarter ended June 27, 2026 (the “first quarter”) of fiscal year 2027.

Continue Reading